Skip to main content
. 2016 Jun 27;10:308. doi: 10.3389/fnhum.2016.00308

Table 1.

Demographic and clinical characteristics of the study sample.

Variables Non responders (n = 23) Responders (n = 10) P
Age (years) 43.36 (14.78) 48.30 (9.13) 0.33
Marital status (married/unmarried) 13/10 4/6 0.31
Education (years) 13.91 (4.25) 12.57 (3.88) 0.37
Smoking (yes/no) 1/22 0/10 0.69
Alcohol consumption (yes/no) 22/1 10/0 0.69
Duration of pain (years) 6.04 (1.64) 6.4 (0.97) 0.42
Pain on visual analog scale (cm) 8 (1.33) 6.5 (1.85) 0.01
Trait-anxiety (STAI-T) 28.82 (6.14) 25.17 (6.41) 0.13
State-anxiety (STA-T) 30.0 (8.42) 29.91 (5.75) 0.98
Beck depression inventory 13.45 (7.04) 15.83 (7.12) 0.37
Brazilian Portuguese Catastrophizing Scale (BP-PCS) 33.82 (6.98) 31.52 (8.14) 0.42
Number of days analgesics were used per week in the last 3 months (< 4 times/= 4 times)a 8/15 2/8 0.33
Presence of other chronic diseases before appearance of pain (yes/no)b 4/19 2/8 0.6
Diagnosis of psychiatric disorders (yes/no) 8/15 5/5 0.32
Active use of central nervous system medication (yes/no)c 20/3 7/3 0.25

Values are given as the mean (SD) or frequency (n = 33).

a

The same patient may have used more than one medication.

b

Chronic diseases other than pain: hypertension (n = 12); ischemic heart disease (n = 1); heart attack (n = 1); diabetes mellitus (n = 5); thyroid diseases (n = 2); other chronic diseases listed (n = 0).

c

Central nervous medication: tricyclic antidepressant (n = 2); topiromate (n = 1); tylex (n = 1).